Current liabilities increased 285.8%
Current liabilities changed +285.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$21.8M→$84.2M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →XTIA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory increased 666.7%
Inventory changed +666.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.5M→$19.1M4 prior comparisons
Trade receivables changed across a low base
Trade receivables changed +3796.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$338,000→$13.2M4 prior comparisons
Free-cash-flow proxy decreased 55.8%
Free-cash-flow proxy changed -55.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-$6.8M→-$10.6M4 prior comparisons
Cash & equivalents decreased 64.0%
Cash & equivalents changed -64.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
$20.0M→$7.2M4 prior comparisons
Operating cash flow decreased 56.6%
Operating cash flow changed -56.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-$6.7M→-$10.6M4 prior comparisons
Gross margin moved 6311 bp lower
Gross margin changed -6311 basis points from the comparable as-filed period.
80.50%→17.39%3 prior comparisons
Operating margin moved 182701 bp higher
Operating margin changed +182701 basis points from the comparable as-filed period.
-1855.00%→-27.99%2 prior comparisons
Operating income increased 18.4%
Operating income changed +18.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$11.1M→-$9.1M3 prior comparisons
Research & development decreased 70.4%
Research & development changed -70.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.0M→$577,0003 prior comparisons
Total assets increased 105.5%
Total assets changed +105.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$35.4M→$72.8M4 prior comparisons
Current assets increased 87.3%
Current assets changed +87.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$24.2M→$45.3M4 prior comparisons
Capex / revenue moved 955 bp lower
Capex / revenue changed -955 basis points from the comparable as-filed period.
9.67%→0.12%2 prior comparisons
Working capital / assets moved 6010 bp lower
Working capital / assets changed -6010 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
6.70%→-53.40%4 prior comparisons
Stock-based compensation increased 422.7%
Stock-based compensation changed +422.7% from the comparable as-filed period.
$722,000→$3.8M3 prior comparisons
Capital expenditure decreased 32.8%
Capital expenditure changed -32.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
$58,000→$39,0004 prior comparisons
Inventory / revenue moved 35616 bp lower
Inventory / revenue changed -35616 basis points from the comparable as-filed period.
415.00%→58.84%3 prior comparisons
Shares outstanding increased 512.0%
Shares outstanding changed +512.0% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
6,287,540→38,477,7897 prior comparisons
Free-cash-flow proxy increased 30.8%
Free-cash-flow proxy changed +30.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$15.3M→-$10.6M3 prior comparisons
Operating cash flow increased 31.4%
Operating cash flow changed +31.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$15.2M→-$10.5M3 prior comparisons
Gross margin moved 5063 bp lower
Gross margin changed -5063 basis points from the comparable as-filed period.
69.21%→18.58%3 prior comparisons
Operating margin moved 211166 bp higher
Operating margin changed +211166 basis points from the comparable as-filed period.
-2149.17%→-37.51%2 prior comparisons
Cash & equivalents increased 89.6%
Cash & equivalents changed +89.6% from the comparable as-filed period.
$8.0M→$15.2M3 prior comparisons
Research & development decreased 30.2%
Research & development changed -30.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.7M→$1.2M3 prior comparisons
Current assets increased 301.8%
Current assets changed +301.8% from the comparable as-filed period.
$12.5M→$50.3M3 prior comparisons
Current liabilities increased 626.7%
Current liabilities changed +626.7% from the comparable as-filed period.
$12.5M→$91.0M3 prior comparisons
Total assets increased 188.8%
Total assets changed +188.8% from the comparable as-filed period.
$27.1M→$78.3M3 prior comparisons
Capex / revenue moved 882 bp lower
Capex / revenue changed -882 basis points from the comparable as-filed period.
9.30%→0.47%2 prior comparisons
Inventory increased 737.5%
Inventory changed +737.5% from the comparable as-filed period.
$2.3M→$19.4M3 prior comparisons
Inventory / revenue moved 40883 bp lower
Inventory / revenue changed -40883 basis points from the comparable as-filed period.
478.93%→70.09%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.